VIRON, INC.
Viron Therapeutics Holdings Inc. is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid 19, is under FDA review.
VIRON, INC.
Industry:
Biopharma Biotechnology Clinical Trials Health Care
Founded:
2019-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.vironinc.com
Total Employee:
11+
Status:
Active
Contact:
617-933-7241
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
SPF Amazon Amazon Virginia Region NameBright
Similar Organizations
JB Therapeutics
JB Therapeutics is a clinical-stage biopharmaceutical company developing innovative therapies for orphan inflammatory diseases.
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Current Advisors List
Current Employees Featured
Founder
Official Site Inspections
http://www.vironinc.com
- Host name: ec2-54-84-240-235.compute-1.amazonaws.com
- IP address: 54.84.240.235
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Viron, Inc."
Viron, Inc. - Crunchbase Company Profile & Funding
Viron Therapeutics Holdings Inc. is a Next-Generation Anti-Viral Technology Company. Viron C1, its first product, a prophylactic against Covid 19, is under FDA review.See details»
Viron Therapeutics Holdings, Inc. - Drug pipelines, Patents, Clinical ...
Explore Viron Therapeutics Holdings, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
VIRON PHASE 2A DATA PUBLISHED IN LEADING …
LONDON, ON, Dec. 16 /PRNewswire/ - Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular...See details»
Viron Therapeutics raises US $20 million
May 16, 2006 · Viron Therapeutics Inc., a clinical stage biopharmaceutical company, today announced the closing of a US $20M Series A financing.See details»
Viron Inc. | Biopharma, Biotechnology, Clinical Trials, Health Care
Http://www.vironinc.com. Total Employee: 11+ Status: Active. Contact: 7819569799See details»
Viron Therapeutics Inc - Official MapQuest
700 Collip Cir Suite 203. London, ON N6G 4X8. +1 (519) 858-5109. http://www.vironinc.com. Viron Therapeutics Inc is a biotechnology company based in London, ON, specializing in the …See details»
Viron Therapeutics Appoints Claude Benedict, M.D. as Senior Vice ...
May 1, 2007 · More information is available at: http://www.vironinc.com. Media Contacts Neil K. WarmaSee details»
Viron Therapeutics Inc.: Contact Details and Business Profile
Http://www.vironinc.com Revenue: $8 million: Employees: 1 (1 on RocketReach) Founded: 1997: Address: 700 Collip CircleUWO Research Park Ste 203, London, Ontario N6G 4X8, CA Phone …See details»
Viron Therapeutics - VentureRadar
Website: http://vironinc.com/ Associated sectors: Biologics; Similar Companies: Zumutor India Privately Held developing next generation biologics for novel targets using proprietary antibody …See details»
Viron Therapeutics Inc. - Company Profiles - BCIQ
For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, …See details»
Viron Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Virion Therapeutics, founded in 2018, is a cutting-edge biotech company aiming to eradicate cancer and chronic infectious diseases. Their mission focuses on revolutionizing …See details»
Viron granted U.S. Patents for Organ Transplant and ... - Newswire
LONDON , ON, Dec. 22 /CNW/ - Viron Therapeutics Inc., a biotechnology company pioneering the development of virally-derived protein therapeutics, today announced that it has been …See details»
Viron Careers - Levels.fyi
VIRON is a company focused on developing advanced medicines and therapeutics for the future. Their goal is to create innovative solutions that can improve the lives of people around the …See details»
Viron Therapeutics Inc. Signs Agreement With Diosynth ... - BioSpace
Oct 24, 2006 · Diosynth Biotechnology is part of Akzo Nobel's human healthcare business unit Organon. The Akzo Nobel Safe Harbor Statement (below) applies to this press release. For …See details»
Viron Therapeutics Asset Profile | Preqin
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service …See details»
Viron reports positive proof of concept results in arthritis
Mar 16, 2010 · /CNW/ - Viron Therapeutics Inc. announced that VT-346, an anti-TNF protein therapeutic, demonstrated positive results in a pivotal proof of concept study in...See details»
Viron Therapeutics Inc. Signs Agreement With Diosynth ... - BioSpace
Oct 24, 2006 · Best Places to Work; Employer Resources; Post Jobs; Talent Solutions; Advertise; Submit a Press ReleaseSee details»
Welcome to WANGO, World Association of Non-Governmental …
WANGO convenes events and provides a wealth of tools and resources that help nonprofits better accomplish their missions. We are a worldwide membership organization, with members in …See details»
VIRON PHASE 2A DATA PUBLISHED IN LEADING …
Dec 16, 2010 · /CNW/ - Viron Therapeutics Inc. today announced that the results of Viron's Phase 2a trial for VT-111 were published today in Circulation: Cardiovascular...See details»
Information and Organization | Journal - ScienceDirect
Information and Organization seeks to publish original articles on the relationships between digital technologies, communication, and organizations. It seeks a scholarly understanding that is …See details»